188 related articles for article (PubMed ID: 36555726)
21. On the Offensive: the Role of Outer Membrane Vesicles in the Successful Dissemination of New Delhi Metallo-β-lactamase (NDM-1).
Martínez MMB; Bonomo RA; Vila AJ; Maffía PC; González LJ
mBio; 2021 Oct; 12(5):e0183621. PubMed ID: 34579567
[TBL] [Abstract][Full Text] [Related]
22. Captopril potentiated meropenem activity against MBL-producing carbapenem-resistant Klebsiella pneumoniae: in vitro and in vivo study.
Zhao D; Li H; Yue C; Sun K; Dai Y; Zhang H; Liu Y; Gao Y; Li J
J Inorg Biochem; 2021 May; 218():111381. PubMed ID: 33647540
[TBL] [Abstract][Full Text] [Related]
23. Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1).
Nagulapalli Venkata KC; Ellebrecht M; Tripathi SK
Eur J Med Chem; 2021 Dec; 225():113747. PubMed ID: 34391033
[TBL] [Abstract][Full Text] [Related]
24. Evolution of New Delhi metallo-β-lactamase (NDM) in the clinic: Effects of NDM mutations on stability, zinc affinity, and mono-zinc activity.
Cheng Z; Thomas PW; Ju L; Bergstrom A; Mason K; Clayton D; Miller C; Bethel CR; VanPelt J; Tierney DL; Page RC; Bonomo RA; Fast W; Crowder MW
J Biol Chem; 2018 Aug; 293(32):12606-12618. PubMed ID: 29909397
[TBL] [Abstract][Full Text] [Related]
25. Kinetics, Thermodynamics, and Structural Effects of Quinoline-2-Carboxylates, Zinc-Binding Inhibitors of New Delhi Metallo-β-lactamase-1 Re-sensitizing Multidrug-Resistant Bacteria for Carbapenems.
Jia Y; Schroeder B; Pfeifer Y; Fröhlich C; Deng L; Arkona C; Kuropka B; Sticht J; Ataka K; Bergemann S; Wolber G; Nitsche C; Mielke M; Leiros HS; Werner G; Rademann J
J Med Chem; 2023 Sep; 66(17):11761-11791. PubMed ID: 37585683
[TBL] [Abstract][Full Text] [Related]
26. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
[TBL] [Abstract][Full Text] [Related]
27. Aurones and derivatives as promising New Delhi metallo-β-lactamase (NDM-1) inhibitors.
Caburet J; Verdirosa F; Moretti M; Roulier B; Simoncelli G; Haudecoeur R; Ghazi S; Jamet H; Docquier JD; Boucherle B; Peuchmaur M
Bioorg Med Chem; 2024 Jan; 97():117559. PubMed ID: 38109811
[TBL] [Abstract][Full Text] [Related]
28. Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Guo Y; Yang Y; Xu X; Li L; Zhou Y; Jia G; Wei L; Yu Q; Wang J
Eur J Med Chem; 2022 Mar; 231():114108. PubMed ID: 35101651
[TBL] [Abstract][Full Text] [Related]
29. Inhibitor and substrate binding by New Delhi metallo-beta-lactamase-1: a molecular dynamics studies.
Wang YT; Lu CY; Hour TC; Cheng TL
Curr Comput Aided Drug Des; 2014; 10(3):197-204. PubMed ID: 25479381
[TBL] [Abstract][Full Text] [Related]
30. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU
Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578
[TBL] [Abstract][Full Text] [Related]
31. Drug Repurposing of the Unithiol: Inhibition of Metallo-β-Lactamases for the Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections.
Grigorenko VG; Khrenova MG; Andreeva IP; Rubtsova MY; Lev AI; Novikova TS; Detusheva EV; Fursova NK; Dyatlov IA; Egorov AM
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163756
[TBL] [Abstract][Full Text] [Related]
32. Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods.
Salari-Jazi A; Mahnam K; Sadeghi P; Damavandi MS; Faghri J
Sci Rep; 2021 Jan; 11(1):2390. PubMed ID: 33504907
[TBL] [Abstract][Full Text] [Related]
33. H
Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S
Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873
[TBL] [Abstract][Full Text] [Related]
34. Ruthenium complexes as prospective inhibitors of metallo-β-lactamases to reverse carbapenem resistance.
Chen C; Yang K
Dalton Trans; 2020 Oct; 49(40):14099-14105. PubMed ID: 32996954
[TBL] [Abstract][Full Text] [Related]
35. Recent research and development of NDM-1 inhibitors.
Wang T; Xu K; Zhao L; Tong R; Xiong L; Shi J
Eur J Med Chem; 2021 Nov; 223():113667. PubMed ID: 34225181
[TBL] [Abstract][Full Text] [Related]
36. Non-active site mutation (Q123A) in New Delhi metallo-β-lactamase (NDM-1) enhanced its enzyme activity.
Ali A; Azam MW; Khan AU
Int J Biol Macromol; 2018 Jun; 112():1272-1277. PubMed ID: 29454953
[TBL] [Abstract][Full Text] [Related]
37. Refined models of New Delhi metallo-beta-lactamase-1 with inhibitors: an QM/MM modeling study.
Wang YT; Cheng TL
J Biomol Struct Dyn; 2016 Oct; 34(10):2214-23. PubMed ID: 26488313
[TBL] [Abstract][Full Text] [Related]
38. Glutamic acid at position 152 and serine at position 191 are key residues required for the metallo-β-lactamase activity of NDM-7.
Kumar G; Issa B; Biswal S; Jain D; Bhattacharjee A; Ghosh AS
Int J Antimicrob Agents; 2020 Jan; 55(1):105824. PubMed ID: 31634553
[TBL] [Abstract][Full Text] [Related]
39. Polypyridine ligands as potential metallo-β-lactamase inhibitors.
La Piana L; Viaggi V; Principe L; Di Bella S; Luzzaro F; Viale M; Bertola N; Vecchio G
J Inorg Biochem; 2021 Feb; 215():111315. PubMed ID: 33285370
[TBL] [Abstract][Full Text] [Related]
40. An integrated biophysical approach to discovering mechanisms of NDM-1 inhibition for several thiol-containing drugs.
Fullington S; Cheng Z; Thomas C; Miller C; Yang K; Ju LC; Bergstrom A; Shurina BA; Bretz SL; Page RC; Tierney DL; Crowder MW
J Biol Inorg Chem; 2020 Aug; 25(5):717-727. PubMed ID: 32500360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
